Metoprolol Eg (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors located mainly in the heart. This inhibition reduces the effects of adrenaline and noradrenaline, leading to a slower heart rate, decreased contractile force, and lower cardiac output. The resulting drop in blood pressure and myocardial oxygen demand underlies its therapeutic benefits in hypertension, angina, and heart failure.

The dose of Metoprolol Eg is individualized and determined by the prescribing clinician based on the specific indication, patient age, renal function, and response to therapy. Dosage may start low and be titrated upward to achieve target blood pressure or heart‑rate goals while monitoring for side effects. Patients should follow the exact regimen provided by their healthcare professional.

The safety of Metoprolol Tartrate in pregnancy and lactation has not been definitively established, and the product’s pregnancy category is listed as unknown. Clinicians must weigh the potential benefits against possible risks to the fetus or infant. If treatment is considered essential, it should be prescribed by a specialist familiar with maternal‑fetal medicine.

To request Metoprolol Eg, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing a formal quotation, availability, shipping details, and any necessary import documentation.

Metoprolol is a cardio‑selective (β1‑selective) beta‑blocker, offering a lower risk of bronchospasm compared with non‑selective agents such as propranolol. It is commonly used for hypertension, angina, and heart failure, whereas some alternatives may be preferred for migraine prophylaxis or tremor control. Choice of agent depends on the patient’s comorbidities, tolerance, and therapeutic goals.

Metoprolol Eg should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Do not store in areas of high humidity or near heat sources. Keep the product out of reach of children and discard any tablets that appear discoloured or damaged.

Metoprolol Eg is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing relative to meals. Tablets should be swallowed whole and not crushed or chewed unless a specific formulation allows it.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing, or signs of an allergic response.

Metoprolol Eg is contraindicated in patients with known hypersensitivity to metoprolol or any excipients, those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and individuals in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma, severe peripheral vascular disease, or decompensated heart failure.